nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ABCB1—Dactinomycin—muscle cancer	0.144	0.34	CbGbCtD
Cilazapril—ABCB1—Vincristine—muscle cancer	0.0888	0.21	CbGbCtD
Cilazapril—ABCB1—Etoposide—muscle cancer	0.0813	0.192	CbGbCtD
Cilazapril—ACE—forelimb zeugopod—muscle cancer	0.0557	0.281	CbGeAlD
Cilazapril—ABCB1—Doxorubicin—muscle cancer	0.0555	0.131	CbGbCtD
Cilazapril—ABCB1—Methotrexate—muscle cancer	0.0537	0.127	CbGbCtD
Cilazapril—ACE—hindlimb—muscle cancer	0.0252	0.127	CbGeAlD
Cilazapril—ACE—arm—muscle cancer	0.0241	0.121	CbGeAlD
Cilazapril—ACE—appendage—muscle cancer	0.0216	0.109	CbGeAlD
Cilazapril—SLC15A1—renal system—muscle cancer	0.00758	0.0382	CbGeAlD
Cilazapril—ACE—embryo—muscle cancer	0.00718	0.0362	CbGeAlD
Cilazapril—ACE—smooth muscle tissue—muscle cancer	0.00564	0.0285	CbGeAlD
Cilazapril—SLC15A1—vagina—muscle cancer	0.00549	0.0277	CbGeAlD
Cilazapril—ACE—renal system—muscle cancer	0.00543	0.0274	CbGeAlD
Cilazapril—ACE—cardiac atrium—muscle cancer	0.00486	0.0245	CbGeAlD
Cilazapril—SLC15A2—renal system—muscle cancer	0.00474	0.0239	CbGeAlD
Cilazapril—ACE—bone marrow—muscle cancer	0.00411	0.0207	CbGeAlD
Cilazapril—ACE—head—muscle cancer	0.00363	0.0183	CbGeAlD
Cilazapril—ACE—testis—muscle cancer	0.00351	0.0177	CbGeAlD
Cilazapril—SLC15A2—vagina—muscle cancer	0.00343	0.0173	CbGeAlD
Cilazapril—SLC15A2—head—muscle cancer	0.00317	0.016	CbGeAlD
Cilazapril—SLC15A2—testis—muscle cancer	0.00306	0.0154	CbGeAlD
Cilazapril—ABCB1—embryo—muscle cancer	0.00253	0.0127	CbGeAlD
Cilazapril—ABCB1—renal system—muscle cancer	0.00191	0.00965	CbGeAlD
Cilazapril—ABCB1—bone marrow—muscle cancer	0.00145	0.0073	CbGeAlD
Cilazapril—ABCB1—vagina—muscle cancer	0.00138	0.00699	CbGeAlD
Cilazapril—ABCB1—head—muscle cancer	0.00128	0.00646	CbGeAlD
Cilazapril—ABCB1—testis—muscle cancer	0.00124	0.00624	CbGeAlD
Cilazapril—Oedema—Vincristine—muscle cancer	0.0012	0.00318	CcSEcCtD
Cilazapril—Thrombocytopenia—Vincristine—muscle cancer	0.00118	0.00311	CcSEcCtD
Cilazapril—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00118	0.00311	CcSEcCtD
Cilazapril—Photosensitivity—Doxorubicin—muscle cancer	0.00117	0.0031	CcSEcCtD
Cilazapril—Decreased appetite—Dactinomycin—muscle cancer	0.00117	0.00309	CcSEcCtD
Cilazapril—Dysgeusia—Etoposide—muscle cancer	0.00117	0.00309	CcSEcCtD
Cilazapril—Hyperhidrosis—Vincristine—muscle cancer	0.00116	0.00307	CcSEcCtD
Cilazapril—Fatigue—Dactinomycin—muscle cancer	0.00116	0.00307	CcSEcCtD
Cilazapril—Pain—Dactinomycin—muscle cancer	0.00115	0.00304	CcSEcCtD
Cilazapril—Vascular purpura—Doxorubicin—muscle cancer	0.00115	0.00304	CcSEcCtD
Cilazapril—Muscle spasms—Etoposide—muscle cancer	0.00115	0.00303	CcSEcCtD
Cilazapril—Anorexia—Vincristine—muscle cancer	0.00115	0.00303	CcSEcCtD
Cilazapril—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00113	0.003	CcSEcCtD
Cilazapril—Hypotension—Vincristine—muscle cancer	0.00112	0.00297	CcSEcCtD
Cilazapril—Ataxia—Methotrexate—muscle cancer	0.00112	0.00295	CcSEcCtD
Cilazapril—Renal failure acute—Doxorubicin—muscle cancer	0.00111	0.00294	CcSEcCtD
Cilazapril—Feeling abnormal—Dactinomycin—muscle cancer	0.00111	0.00293	CcSEcCtD
Cilazapril—Ill-defined disorder—Etoposide—muscle cancer	0.00111	0.00293	CcSEcCtD
Cilazapril—Anaemia—Etoposide—muscle cancer	0.0011	0.00292	CcSEcCtD
Cilazapril—Gastrointestinal pain—Dactinomycin—muscle cancer	0.0011	0.00291	CcSEcCtD
Cilazapril—Hot flush—Doxorubicin—muscle cancer	0.0011	0.00291	CcSEcCtD
Cilazapril—Liver function test abnormal—Methotrexate—muscle cancer	0.0011	0.0029	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Vincristine—muscle cancer	0.0011	0.0029	CcSEcCtD
Cilazapril—Menopausal symptoms—Doxorubicin—muscle cancer	0.00109	0.00288	CcSEcCtD
Cilazapril—Insomnia—Vincristine—muscle cancer	0.00109	0.00288	CcSEcCtD
Cilazapril—Renal impairment—Doxorubicin—muscle cancer	0.00108	0.00286	CcSEcCtD
Cilazapril—Paraesthesia—Vincristine—muscle cancer	0.00108	0.00286	CcSEcCtD
Cilazapril—Malaise—Etoposide—muscle cancer	0.00108	0.00285	CcSEcCtD
Cilazapril—Vertigo—Etoposide—muscle cancer	0.00107	0.00284	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00107	0.00283	CcSEcCtD
Cilazapril—Leukopenia—Etoposide—muscle cancer	0.00107	0.00283	CcSEcCtD
Cilazapril—Purpura—Doxorubicin—muscle cancer	0.00107	0.00282	CcSEcCtD
Cilazapril—Abdominal pain—Dactinomycin—muscle cancer	0.00106	0.00281	CcSEcCtD
Cilazapril—Cardiac failure—Doxorubicin—muscle cancer	0.00105	0.00279	CcSEcCtD
Cilazapril—Loss of consciousness—Etoposide—muscle cancer	0.00105	0.00277	CcSEcCtD
Cilazapril—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00105	0.00277	CcSEcCtD
Cilazapril—Decreased appetite—Vincristine—muscle cancer	0.00105	0.00276	CcSEcCtD
Cilazapril—Cough—Etoposide—muscle cancer	0.00104	0.00275	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Vincristine—muscle cancer	0.00104	0.00275	CcSEcCtD
Cilazapril—Fatigue—Vincristine—muscle cancer	0.00104	0.00274	CcSEcCtD
Cilazapril—Hypertension—Etoposide—muscle cancer	0.00103	0.00273	CcSEcCtD
Cilazapril—Pain—Vincristine—muscle cancer	0.00103	0.00272	CcSEcCtD
Cilazapril—Constipation—Vincristine—muscle cancer	0.00103	0.00272	CcSEcCtD
Cilazapril—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00103	0.00272	CcSEcCtD
Cilazapril—Chest pain—Etoposide—muscle cancer	0.00102	0.00269	CcSEcCtD
Cilazapril—Migraine—Doxorubicin—muscle cancer	0.00101	0.00268	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00101	0.00267	CcSEcCtD
Cilazapril—Pancreatitis—Methotrexate—muscle cancer	0.00101	0.00266	CcSEcCtD
Cilazapril—Discomfort—Etoposide—muscle cancer	0.001	0.00265	CcSEcCtD
Cilazapril—Face oedema—Doxorubicin—muscle cancer	0.000993	0.00262	CcSEcCtD
Cilazapril—Hypersensitivity—Dactinomycin—muscle cancer	0.000992	0.00262	CcSEcCtD
Cilazapril—Gastrointestinal pain—Vincristine—muscle cancer	0.000984	0.0026	CcSEcCtD
Cilazapril—Confusional state—Etoposide—muscle cancer	0.000983	0.0026	CcSEcCtD
Cilazapril—Ataxia—Doxorubicin—muscle cancer	0.000967	0.00256	CcSEcCtD
Cilazapril—Asthenia—Dactinomycin—muscle cancer	0.000966	0.00255	CcSEcCtD
Cilazapril—Neutropenia—Methotrexate—muscle cancer	0.00096	0.00254	CcSEcCtD
Cilazapril—Dysuria—Methotrexate—muscle cancer	0.00096	0.00254	CcSEcCtD
Cilazapril—Thrombocytopenia—Etoposide—muscle cancer	0.000954	0.00252	CcSEcCtD
Cilazapril—Tachycardia—Etoposide—muscle cancer	0.000951	0.00251	CcSEcCtD
Cilazapril—Abdominal pain—Vincristine—muscle cancer	0.000951	0.00251	CcSEcCtD
Cilazapril—Liver function test abnormal—Doxorubicin—muscle cancer	0.00095	0.00251	CcSEcCtD
Cilazapril—Skin disorder—Etoposide—muscle cancer	0.000947	0.0025	CcSEcCtD
Cilazapril—Erectile dysfunction—Methotrexate—muscle cancer	0.000946	0.0025	CcSEcCtD
Cilazapril—Hyperhidrosis—Etoposide—muscle cancer	0.000942	0.00249	CcSEcCtD
Cilazapril—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000939	0.00248	CcSEcCtD
Cilazapril—Photosensitivity reaction—Methotrexate—muscle cancer	0.000937	0.00248	CcSEcCtD
Cilazapril—Anorexia—Etoposide—muscle cancer	0.000929	0.00246	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000926	0.00245	CcSEcCtD
Cilazapril—Diarrhoea—Dactinomycin—muscle cancer	0.000921	0.00244	CcSEcCtD
Cilazapril—Hypotension—Etoposide—muscle cancer	0.000911	0.00241	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000908	0.0024	CcSEcCtD
Cilazapril—Renal failure—Methotrexate—muscle cancer	0.0009	0.00238	CcSEcCtD
Cilazapril—Conjunctivitis—Methotrexate—muscle cancer	0.00089	0.00235	CcSEcCtD
Cilazapril—Hypersensitivity—Vincristine—muscle cancer	0.000887	0.00234	CcSEcCtD
Cilazapril—Paraesthesia—Etoposide—muscle cancer	0.000875	0.00231	CcSEcCtD
Cilazapril—Pancreatitis—Doxorubicin—muscle cancer	0.000872	0.0023	CcSEcCtD
Cilazapril—Dyspnoea—Etoposide—muscle cancer	0.000869	0.0023	CcSEcCtD
Cilazapril—Somnolence—Etoposide—muscle cancer	0.000867	0.00229	CcSEcCtD
Cilazapril—Angina pectoris—Doxorubicin—muscle cancer	0.000866	0.00229	CcSEcCtD
Cilazapril—Hepatobiliary disease—Methotrexate—muscle cancer	0.000866	0.00229	CcSEcCtD
Cilazapril—Epistaxis—Methotrexate—muscle cancer	0.000863	0.00228	CcSEcCtD
Cilazapril—Asthenia—Vincristine—muscle cancer	0.000863	0.00228	CcSEcCtD
Cilazapril—Vomiting—Dactinomycin—muscle cancer	0.000856	0.00226	CcSEcCtD
Cilazapril—Bronchitis—Doxorubicin—muscle cancer	0.000855	0.00226	CcSEcCtD
Cilazapril—Agranulocytosis—Methotrexate—muscle cancer	0.000854	0.00226	CcSEcCtD
Cilazapril—Rash—Dactinomycin—muscle cancer	0.000849	0.00224	CcSEcCtD
Cilazapril—Decreased appetite—Etoposide—muscle cancer	0.000847	0.00224	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Etoposide—muscle cancer	0.000842	0.00222	CcSEcCtD
Cilazapril—Fatigue—Etoposide—muscle cancer	0.00084	0.00222	CcSEcCtD
Cilazapril—Pain—Etoposide—muscle cancer	0.000834	0.0022	CcSEcCtD
Cilazapril—Constipation—Etoposide—muscle cancer	0.000834	0.0022	CcSEcCtD
Cilazapril—Dysuria—Doxorubicin—muscle cancer	0.000831	0.0022	CcSEcCtD
Cilazapril—Neutropenia—Doxorubicin—muscle cancer	0.000831	0.0022	CcSEcCtD
Cilazapril—Diarrhoea—Vincristine—muscle cancer	0.000823	0.00218	CcSEcCtD
Cilazapril—Pollakiuria—Doxorubicin—muscle cancer	0.000821	0.00217	CcSEcCtD
Cilazapril—Pharyngitis—Methotrexate—muscle cancer	0.000816	0.00216	CcSEcCtD
Cilazapril—Urinary tract disorder—Methotrexate—muscle cancer	0.000812	0.00214	CcSEcCtD
Cilazapril—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000811	0.00214	CcSEcCtD
Cilazapril—Urethral disorder—Methotrexate—muscle cancer	0.000806	0.00213	CcSEcCtD
Cilazapril—Feeling abnormal—Etoposide—muscle cancer	0.000803	0.00212	CcSEcCtD
Cilazapril—Hyperglycaemia—Doxorubicin—muscle cancer	0.000802	0.00212	CcSEcCtD
Cilazapril—Nausea—Dactinomycin—muscle cancer	0.0008	0.00211	CcSEcCtD
Cilazapril—Gastrointestinal pain—Etoposide—muscle cancer	0.000797	0.00211	CcSEcCtD
Cilazapril—Dizziness—Vincristine—muscle cancer	0.000796	0.0021	CcSEcCtD
Cilazapril—Visual impairment—Methotrexate—muscle cancer	0.000792	0.00209	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000786	0.00208	CcSEcCtD
Cilazapril—Renal failure—Doxorubicin—muscle cancer	0.000779	0.00206	CcSEcCtD
Cilazapril—Erythema multiforme—Methotrexate—muscle cancer	0.000777	0.00205	CcSEcCtD
Cilazapril—Urticaria—Etoposide—muscle cancer	0.000774	0.00205	CcSEcCtD
Cilazapril—Abdominal pain—Etoposide—muscle cancer	0.000771	0.00204	CcSEcCtD
Cilazapril—Conjunctivitis—Doxorubicin—muscle cancer	0.000771	0.00204	CcSEcCtD
Cilazapril—Tinnitus—Methotrexate—muscle cancer	0.000766	0.00202	CcSEcCtD
Cilazapril—Vomiting—Vincristine—muscle cancer	0.000765	0.00202	CcSEcCtD
Cilazapril—Cardiac disorder—Methotrexate—muscle cancer	0.000763	0.00202	CcSEcCtD
Cilazapril—Rash—Vincristine—muscle cancer	0.000759	0.00201	CcSEcCtD
Cilazapril—Dermatitis—Vincristine—muscle cancer	0.000758	0.002	CcSEcCtD
Cilazapril—Headache—Vincristine—muscle cancer	0.000754	0.00199	CcSEcCtD
Cilazapril—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00075	0.00198	CcSEcCtD
Cilazapril—Epistaxis—Doxorubicin—muscle cancer	0.000748	0.00198	CcSEcCtD
Cilazapril—Angiopathy—Methotrexate—muscle cancer	0.000746	0.00197	CcSEcCtD
Cilazapril—Sinusitis—Doxorubicin—muscle cancer	0.000744	0.00197	CcSEcCtD
Cilazapril—Immune system disorder—Methotrexate—muscle cancer	0.000742	0.00196	CcSEcCtD
Cilazapril—Agranulocytosis—Doxorubicin—muscle cancer	0.00074	0.00195	CcSEcCtD
Cilazapril—Chills—Methotrexate—muscle cancer	0.000737	0.00195	CcSEcCtD
Cilazapril—Alopecia—Methotrexate—muscle cancer	0.000726	0.00192	CcSEcCtD
Cilazapril—Bradycardia—Doxorubicin—muscle cancer	0.000724	0.00191	CcSEcCtD
Cilazapril—Hypersensitivity—Etoposide—muscle cancer	0.000718	0.0019	CcSEcCtD
Cilazapril—Nausea—Vincristine—muscle cancer	0.000715	0.00189	CcSEcCtD
Cilazapril—Rhinitis—Doxorubicin—muscle cancer	0.000713	0.00189	CcSEcCtD
Cilazapril—Hypoaesthesia—Doxorubicin—muscle cancer	0.000708	0.00187	CcSEcCtD
Cilazapril—Pharyngitis—Doxorubicin—muscle cancer	0.000706	0.00187	CcSEcCtD
Cilazapril—Urinary tract disorder—Doxorubicin—muscle cancer	0.000703	0.00186	CcSEcCtD
Cilazapril—Dysgeusia—Methotrexate—muscle cancer	0.000701	0.00185	CcSEcCtD
Cilazapril—Asthenia—Etoposide—muscle cancer	0.000699	0.00185	CcSEcCtD
Cilazapril—Urethral disorder—Doxorubicin—muscle cancer	0.000698	0.00184	CcSEcCtD
Cilazapril—Pruritus—Etoposide—muscle cancer	0.00069	0.00182	CcSEcCtD
Cilazapril—Visual impairment—Doxorubicin—muscle cancer	0.000686	0.00181	CcSEcCtD
Cilazapril—Erythema multiforme—Doxorubicin—muscle cancer	0.000673	0.00178	CcSEcCtD
Cilazapril—Diarrhoea—Etoposide—muscle cancer	0.000667	0.00176	CcSEcCtD
Cilazapril—Ill-defined disorder—Methotrexate—muscle cancer	0.000664	0.00175	CcSEcCtD
Cilazapril—Tinnitus—Doxorubicin—muscle cancer	0.000663	0.00175	CcSEcCtD
Cilazapril—Anaemia—Methotrexate—muscle cancer	0.000661	0.00175	CcSEcCtD
Cilazapril—Cardiac disorder—Doxorubicin—muscle cancer	0.00066	0.00175	CcSEcCtD
Cilazapril—Flushing—Doxorubicin—muscle cancer	0.00066	0.00175	CcSEcCtD
Cilazapril—Angiopathy—Doxorubicin—muscle cancer	0.000646	0.00171	CcSEcCtD
Cilazapril—Malaise—Methotrexate—muscle cancer	0.000645	0.0017	CcSEcCtD
Cilazapril—Dizziness—Etoposide—muscle cancer	0.000645	0.0017	CcSEcCtD
Cilazapril—Immune system disorder—Doxorubicin—muscle cancer	0.000643	0.0017	CcSEcCtD
Cilazapril—Vertigo—Methotrexate—muscle cancer	0.000643	0.0017	CcSEcCtD
Cilazapril—Leukopenia—Methotrexate—muscle cancer	0.00064	0.00169	CcSEcCtD
Cilazapril—Chills—Doxorubicin—muscle cancer	0.000639	0.00169	CcSEcCtD
Cilazapril—Arrhythmia—Doxorubicin—muscle cancer	0.000636	0.00168	CcSEcCtD
Cilazapril—Alopecia—Doxorubicin—muscle cancer	0.000629	0.00166	CcSEcCtD
Cilazapril—Cough—Methotrexate—muscle cancer	0.000624	0.00165	CcSEcCtD
Cilazapril—Vomiting—Etoposide—muscle cancer	0.00062	0.00164	CcSEcCtD
Cilazapril—Rash—Etoposide—muscle cancer	0.000615	0.00162	CcSEcCtD
Cilazapril—Dermatitis—Etoposide—muscle cancer	0.000614	0.00162	CcSEcCtD
Cilazapril—Headache—Etoposide—muscle cancer	0.000611	0.00161	CcSEcCtD
Cilazapril—Flatulence—Doxorubicin—muscle cancer	0.00061	0.00161	CcSEcCtD
Cilazapril—Chest pain—Methotrexate—muscle cancer	0.000609	0.00161	CcSEcCtD
Cilazapril—Myalgia—Methotrexate—muscle cancer	0.000609	0.00161	CcSEcCtD
Cilazapril—Arthralgia—Methotrexate—muscle cancer	0.000609	0.00161	CcSEcCtD
Cilazapril—Tension—Doxorubicin—muscle cancer	0.000608	0.00161	CcSEcCtD
Cilazapril—Dysgeusia—Doxorubicin—muscle cancer	0.000607	0.0016	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000605	0.0016	CcSEcCtD
Cilazapril—Discomfort—Methotrexate—muscle cancer	0.000602	0.00159	CcSEcCtD
Cilazapril—Nervousness—Doxorubicin—muscle cancer	0.000602	0.00159	CcSEcCtD
Cilazapril—Muscle spasms—Doxorubicin—muscle cancer	0.000596	0.00157	CcSEcCtD
Cilazapril—Confusional state—Methotrexate—muscle cancer	0.000589	0.00156	CcSEcCtD
Cilazapril—Nausea—Etoposide—muscle cancer	0.000579	0.00153	CcSEcCtD
Cilazapril—Ill-defined disorder—Doxorubicin—muscle cancer	0.000575	0.00152	CcSEcCtD
Cilazapril—Anaemia—Doxorubicin—muscle cancer	0.000573	0.00151	CcSEcCtD
Cilazapril—Thrombocytopenia—Methotrexate—muscle cancer	0.000572	0.00151	CcSEcCtD
Cilazapril—Skin disorder—Methotrexate—muscle cancer	0.000567	0.0015	CcSEcCtD
Cilazapril—Hyperhidrosis—Methotrexate—muscle cancer	0.000564	0.00149	CcSEcCtD
Cilazapril—Malaise—Doxorubicin—muscle cancer	0.000559	0.00148	CcSEcCtD
Cilazapril—Vertigo—Doxorubicin—muscle cancer	0.000557	0.00147	CcSEcCtD
Cilazapril—Anorexia—Methotrexate—muscle cancer	0.000557	0.00147	CcSEcCtD
Cilazapril—Syncope—Doxorubicin—muscle cancer	0.000556	0.00147	CcSEcCtD
Cilazapril—Leukopenia—Doxorubicin—muscle cancer	0.000554	0.00147	CcSEcCtD
Cilazapril—Palpitations—Doxorubicin—muscle cancer	0.000547	0.00145	CcSEcCtD
Cilazapril—Hypotension—Methotrexate—muscle cancer	0.000546	0.00144	CcSEcCtD
Cilazapril—Loss of consciousness—Doxorubicin—muscle cancer	0.000544	0.00144	CcSEcCtD
Cilazapril—Cough—Doxorubicin—muscle cancer	0.000541	0.00143	CcSEcCtD
Cilazapril—Hypertension—Doxorubicin—muscle cancer	0.000535	0.00141	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000532	0.00141	CcSEcCtD
Cilazapril—Insomnia—Methotrexate—muscle cancer	0.000528	0.0014	CcSEcCtD
Cilazapril—Arthralgia—Doxorubicin—muscle cancer	0.000527	0.00139	CcSEcCtD
Cilazapril—Myalgia—Doxorubicin—muscle cancer	0.000527	0.00139	CcSEcCtD
Cilazapril—Chest pain—Doxorubicin—muscle cancer	0.000527	0.00139	CcSEcCtD
Cilazapril—Anxiety—Doxorubicin—muscle cancer	0.000526	0.00139	CcSEcCtD
Cilazapril—Paraesthesia—Methotrexate—muscle cancer	0.000524	0.00139	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000524	0.00138	CcSEcCtD
Cilazapril—Discomfort—Doxorubicin—muscle cancer	0.000521	0.00138	CcSEcCtD
Cilazapril—Dyspnoea—Methotrexate—muscle cancer	0.000521	0.00138	CcSEcCtD
Cilazapril—Somnolence—Methotrexate—muscle cancer	0.000519	0.00137	CcSEcCtD
Cilazapril—Dry mouth—Doxorubicin—muscle cancer	0.000516	0.00136	CcSEcCtD
Cilazapril—Dyspepsia—Methotrexate—muscle cancer	0.000514	0.00136	CcSEcCtD
Cilazapril—Confusional state—Doxorubicin—muscle cancer	0.00051	0.00135	CcSEcCtD
Cilazapril—Decreased appetite—Methotrexate—muscle cancer	0.000508	0.00134	CcSEcCtD
Cilazapril—Oedema—Doxorubicin—muscle cancer	0.000506	0.00134	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000504	0.00133	CcSEcCtD
Cilazapril—Fatigue—Methotrexate—muscle cancer	0.000503	0.00133	CcSEcCtD
Cilazapril—Pain—Methotrexate—muscle cancer	0.000499	0.00132	CcSEcCtD
Cilazapril—Shock—Doxorubicin—muscle cancer	0.000497	0.00131	CcSEcCtD
Cilazapril—Thrombocytopenia—Doxorubicin—muscle cancer	0.000495	0.00131	CcSEcCtD
Cilazapril—Tachycardia—Doxorubicin—muscle cancer	0.000493	0.0013	CcSEcCtD
Cilazapril—Skin disorder—Doxorubicin—muscle cancer	0.000491	0.0013	CcSEcCtD
Cilazapril—Hyperhidrosis—Doxorubicin—muscle cancer	0.000489	0.00129	CcSEcCtD
Cilazapril—Anorexia—Doxorubicin—muscle cancer	0.000482	0.00127	CcSEcCtD
Cilazapril—Feeling abnormal—Methotrexate—muscle cancer	0.000481	0.00127	CcSEcCtD
Cilazapril—Gastrointestinal pain—Methotrexate—muscle cancer	0.000477	0.00126	CcSEcCtD
Cilazapril—Hypotension—Doxorubicin—muscle cancer	0.000472	0.00125	CcSEcCtD
Cilazapril—Urticaria—Methotrexate—muscle cancer	0.000464	0.00123	CcSEcCtD
Cilazapril—Abdominal pain—Methotrexate—muscle cancer	0.000462	0.00122	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000461	0.00122	CcSEcCtD
Cilazapril—Insomnia—Doxorubicin—muscle cancer	0.000457	0.00121	CcSEcCtD
Cilazapril—Paraesthesia—Doxorubicin—muscle cancer	0.000454	0.0012	CcSEcCtD
Cilazapril—Dyspnoea—Doxorubicin—muscle cancer	0.000451	0.00119	CcSEcCtD
Cilazapril—Somnolence—Doxorubicin—muscle cancer	0.000449	0.00119	CcSEcCtD
Cilazapril—Dyspepsia—Doxorubicin—muscle cancer	0.000445	0.00118	CcSEcCtD
Cilazapril—Decreased appetite—Doxorubicin—muscle cancer	0.000439	0.00116	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000436	0.00115	CcSEcCtD
Cilazapril—Fatigue—Doxorubicin—muscle cancer	0.000436	0.00115	CcSEcCtD
Cilazapril—Pain—Doxorubicin—muscle cancer	0.000432	0.00114	CcSEcCtD
Cilazapril—Constipation—Doxorubicin—muscle cancer	0.000432	0.00114	CcSEcCtD
Cilazapril—Hypersensitivity—Methotrexate—muscle cancer	0.00043	0.00114	CcSEcCtD
Cilazapril—Asthenia—Methotrexate—muscle cancer	0.000419	0.00111	CcSEcCtD
Cilazapril—Feeling abnormal—Doxorubicin—muscle cancer	0.000417	0.0011	CcSEcCtD
Cilazapril—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000413	0.00109	CcSEcCtD
Cilazapril—Pruritus—Methotrexate—muscle cancer	0.000413	0.00109	CcSEcCtD
Cilazapril—Urticaria—Doxorubicin—muscle cancer	0.000402	0.00106	CcSEcCtD
Cilazapril—Abdominal pain—Doxorubicin—muscle cancer	0.0004	0.00106	CcSEcCtD
Cilazapril—Diarrhoea—Methotrexate—muscle cancer	0.000399	0.00106	CcSEcCtD
Cilazapril—Dizziness—Methotrexate—muscle cancer	0.000386	0.00102	CcSEcCtD
Cilazapril—Hypersensitivity—Doxorubicin—muscle cancer	0.000372	0.000984	CcSEcCtD
Cilazapril—Vomiting—Methotrexate—muscle cancer	0.000371	0.000981	CcSEcCtD
Cilazapril—Rash—Methotrexate—muscle cancer	0.000368	0.000973	CcSEcCtD
Cilazapril—Dermatitis—Methotrexate—muscle cancer	0.000368	0.000972	CcSEcCtD
Cilazapril—Headache—Methotrexate—muscle cancer	0.000366	0.000967	CcSEcCtD
Cilazapril—Asthenia—Doxorubicin—muscle cancer	0.000363	0.000959	CcSEcCtD
Cilazapril—Pruritus—Doxorubicin—muscle cancer	0.000358	0.000945	CcSEcCtD
Cilazapril—Nausea—Methotrexate—muscle cancer	0.000347	0.000917	CcSEcCtD
Cilazapril—Diarrhoea—Doxorubicin—muscle cancer	0.000346	0.000914	CcSEcCtD
Cilazapril—Dizziness—Doxorubicin—muscle cancer	0.000334	0.000884	CcSEcCtD
Cilazapril—Vomiting—Doxorubicin—muscle cancer	0.000321	0.000849	CcSEcCtD
Cilazapril—Rash—Doxorubicin—muscle cancer	0.000319	0.000842	CcSEcCtD
Cilazapril—Dermatitis—Doxorubicin—muscle cancer	0.000318	0.000842	CcSEcCtD
Cilazapril—Headache—Doxorubicin—muscle cancer	0.000317	0.000837	CcSEcCtD
Cilazapril—Nausea—Doxorubicin—muscle cancer	0.0003	0.000794	CcSEcCtD
